ABSTRACT We have previously reported that left ventricular hypcrtrophy in two-kidney, one-clip renal hypertensive rats (2K-iC RHRs) was associated with dimiinished inotropic responsiveniess to isoproterenol and glucagon, suggesting an alteration in the receptor-adenylate cyclase cascade. The present study was perfornmed to investigate the hypothesis that in these same hearts, inotropic responses to a-adrenergic stimuli could be enhanced as a comlpensatory miechanism. 
myocardial flow rates (RHR hearts perfused at 80 mm Hg vs control hearts perfused at 50 mm Hg). Quantitative assessment of number of a,-adrenergic receptors (3H-prazosin binding) showed a significant decrease compared with that in age-matched sham-operated norimiotensive control rats (45 ± 2.5 vs 64 ± 1.7 fmol/mg protein, p < .001). These results indicate that impaired inotropic responsiveness to adrenergic stimuli in left ventricular hypertrophy is not only related to ,3-agonists or adenylate cyclase activators but also involves a-adrenergic stimulants, and that the latter may be related to reduced density of left ventricular aC-receptors.
Circulation 71, No. 5, 1023-1028, 1985. WE HAVE PREVIOUSLY REPORTED that left ventricular hypertrophy in two-kidney, one-clip renal hypertensive rats (2K-iC RHRs) was associated with diminished inotropic responsiveness to /8-adrenergic stimulation by isoproterenolI-' and to non-3-receptormediated stimulation of the adenyl cyclase systeimi by glucagon4 or vasoactive intestinal peptide. * Thus, a question was raised regarding the compenlsatory mechanismis that can help the hypertrophied heart maintain cardiac performance under stressful conditions. Since a-adrenergic stinmulation was first shown by Wenzel and Su5 and later confirmied by others`to have a positive inotropic effect, we investigated the possibility that a-adrenergic responsiveness nmight be increased to compensate for the reduced /8-adrenergic function. In this respect, Kunos et al.9 reported that the isoproterenol/phenylephrine potency ratio in isolated atria was significantly lower in spontaneously hypertensive rats (SHRs) than in nortnotetisive conitrols, while we.
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ii_ C i0-7 10-6 PHENYLEPHRINE (M) ingly stimulated as a possible compensatory mechanism to override the blunting of end-organ responsiveness; this overactivity is particularly evident in advanced dysfunction and cardiac failure. 20 Until recently most studies of cardioadrenergic support dealt with the better known ,B-adrenergic system. However, after the development of an assay for azreceptors,14 a large body of evidence has been obtained demonstrating the presence of a-adrenergic receptors in cardiac muscle. The balance of a-and /3-receptors in the myocardium was shown to be altered by temperature21 and thyroid hormone,22 as well as in different types of hypertension. I 23 Since a-adrenergic stimulation was also shown to have a definite cardiac inotropic effect,5 8, 24 it is possible to hypothesize that in the earlier stages of compensated left ventricular hypertrophy, the balance between the /3 and a components of the adrenergic nervous system is readjusted by increasing responsiveness to a-stimulation that develops to compensate for diminished /3 responses. Extending the work of Woodcock and Johnstonll in 1K-IC RHRs, our results in the 2K-iC preparation confirmed the reduction of myocardial ai-adrenoceptors. However, very little is known regarding the functional consquences of these changes in cardiac oaadrenoceptors; extrapolation from changes in number or affinity to parallel alterations in responsiveness would be hazardous at best and sometimes erroneous.
A single report by Kunos et al.' described a reduction in response of the left atrium of the SHR to phenylephrine (in terms of maximal increase in force), but no change in EC50 (effective concentration for 50% of the group) values; they ascribed their results to reduced sensitivity of the SHR to /3-stimulation. The data obtained in our study are the first demonstration of a significant reduction in ventricular inotropic response to a,-stimulation. This reduction was highly significant under all conditions of the study, irrespective of the perfusion pressure or of myocardial flow rate at which the inotropic response was determined ( figures  1 to 3 the Frank-Starling mechanism) to maintain cardiac performnance. Alternatively, the sympathetic nervous system may be activated even at rest to compensate for the blunted responsiveness of the end organ; this increased adrenergic activity may initiate further injury to the myocardial cell membranes. A vicious cycle could thus be created that might eventually result in cardiac decompensation. 1, 28
